Period | CH20 | ||
---|---|---|---|
BW (50 μg/kg/min) | BW (30 μg/kg/min) | SNC80 (5 mg/kg) | |
C | −31.6 ± 8.3 | −29.7 ± 4.9 | −19.1 ± 2.3 |
B1/S1 | −14.4 ± 1.1 | −7.3 ± 4.51-a | −11.9 ± 3.7 |
B2/S2 | −9.0 ± 3.3 | −12.5 ± 3.3 | −3.1 ± 7.1 |
B3/S3 | −15.3 ± 4.8 | −17.9 ± 1.7 | −3.7 ± 4.0 |
B4/S4 | −14.9 ± 3.1 | −32.6 ± 8.9 | −13.2 ± 3.7 |
B5/S5 | −27.6 ± 9.5 | −16.7 ± 2.4 | −13.2 ± 3.9 |
B6/S6 | −28.1 ± 4.3 | −13.8 ± 7.1 | −18.1 ± 2.4 |
Changes in free water clearance (CH20) produced by the administration of the delta opioid agonist BW373U86 (50 μg/kg/min, n = 5; 30 μg/kg/min i.v.,n = 7), or SNC80 (5 mg/kg, i.v. bolus,n = 5). The values presented are calculated from renal excretory data obtained from the same groups of rats depicted in figures 1 and 3, respectively. Urine samples were collected during control (C, 20 min), and after the administration of either BW (B1 to B6, six consecutive 10 min urine samples beginning 5 min after the start of infusion) or SNC80 (S1 to S6, six consecutive 10 min urine samples beginning immediately after i.v. injection). The values are mean ± S.E.
↵1-a P < .05, significantly different from corresponding control.
Abbreviations are the same as in figure 1.